Skip to main content
Home

Breadcrumb

  1. Home
  2. News
  3. Search results
Displaying results 326 - 350 of 673 Clear search
Zyme Communications
Healthcare and Life Science 24 Jul 2024

Kadans Science Partner commences work on new purpose-built wet lab facilities at Merlin Place, North Cambridge

New facilities adjacent to the Cambridge Science Park will comprise CL2 wet labs, dry labs and office space over six storeys Latest ground-up development in Cambridge delivered by Kadans Science Partner to provide the facilities needed by health, life science and te
Zyme Communications
Healthcare and Life Science 24 Jul 2024

Bio-Rad outlines its advances leveraging droplet digital PCR in biopharma and translational research sectors

Strategic Collaborations in Molecular Residual Disease Monitoring of Cancer and Product Launches in ddPCR Portfolio Advance Corporate Strategy in H1 2024

Zyme Communications
Healthcare and Life Science 23 Jul 2024

Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer

Appointment of experienced preclinical CRO specialist to support accelerated expansion into key global markets

Cambridge, UK, 23 July 2024: Metrion Biosciences Ltd, the specialist preclinical contract research organisation (CRO) and a leader

Zyme Communications
Healthcare and Life Science 23 Jul 2024

Enterprise Therapeutics doses first person with Cystic Fibrosis in Phase 2 Trial for novel therapy ETD001

Trial aims to deliver clinical proof-of-concept and assess the safety profile of novel long acting ENaC inhibitor ETD001 ETD001, a CFTR mutation agnostic approach to CF, is focussed on providing a novel treatment for members of the CF community that do not benefit f
Zyme Communications
Healthcare and Life Science 23 Jul 2024

Lario Therapeutics awarded $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research

Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Parkinson's disease Programme in collaboration with the Oxford Parkinson’s Disease Centre

Edinburgh, U

Zyme Communications
Healthcare and Life Science, Science and Engineering 16 Jul 2024

Sapio Sciences launches Partner program to accelerate research and diagnostics

Baltimore, MD — Sapio Sciences, the science-awareTM lab informatics platform, announces the

Zyme Communications
Healthcare and Life Science 11 Jul 2024

Cellular Origins appoints Geoffrey Hodge as Non-Executive Director

Appointment brings additional significant strategic, technical and commercial experience to the Board

Zyme Communications
Healthcare and Life Science 10 Jul 2024

Closed Loop Medicine selected to join NVIDIA Inception

London, UK: Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug-plus-software precision therapy products that deliver personalized dose optimization to treat the individual, not just the disease, has joined the NVIDIA Inception program.

Zyme Communications
Healthcare and Life Science 09 Jul 2024

Newcells Biotech appoints Emile Shaffu as Director of Sales

Key commercial appointment follows a series of executive team changes to support ongoing company expansion

Zyme Communications
Healthcare and Life Science 08 Jul 2024

H.E.L Group appoints Professor Yih-Shing Duh as Chief Scientific Advisor

Expert in battery testing further strengthens H.E.L’s expertise in thermal safety Professor Duh will be delivering two seminars on behalf of H.E.L Group on 11-12th July at Xiamen University, demonstrating application of H.E.L’s BTC adiab
Zyme Communications
Healthcare and Life Science 02 Jul 2024

Cellular Origins acquires ACTIA Platform IP to enhance automated cell therapy manufacturing

Autologous Cell Therapy Industrial Automation (ACTIA) strengthens technology and IP portfolio of Cellular Origins supporting ongoing development and expanding capabilities of Constellation platform

Zyme Communications
Healthcare and Life Science 02 Jul 2024

Bio-Rad launches ChemiDoc Go Imaging System

Compact system uses CMOS Digital Imaging and is compatible with chemiluminescence and fluorescence detection and stain-free technology

HERCULES, Calif.

Zyme Communications
Healthcare and Life Science 27 Jun 2024

Bio-Rad launches Celselect Slides 2.0 to advance rare cell and circulating tumor cell enrichment for cancer research

New Celselect Slides™ Design Increases Efficiency of Circulating Tumor Cell Capture from Liquid Biopsy Samples for Enumeration and Downstream Applications

Hercules Calif. — Bio-Rad Laboratories, Inc.

Zyme Communications
Healthcare and Life Science 25 Jun 2024

Sapio Sciences introduces Sapio GMP LIMS offering unmatched flexibility for unique manufacturing processes

Sapio Sciences announces key new capabilities to its highly flexible, no/low-code LIMS to support laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standards

Baltimore, MD: Sapio Sciences

Zyme Communications
Healthcare and Life Science 24 Jun 2024

Bio-Rad extends range of anti-biotherapeutic antibodies to accelerate antibody drug development

Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials

Hercules, Calif - Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products

Zyme Communications
Healthcare and Life Science 20 Jun 2024

Bio-Rad launches ddSEQ™ Single-Cell 3' RNA-Seq Kit for Single-Cell Gene Expression

ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 Analysis Software Enable High-Quality and Affordable Single-Cell Transcription and Gene Expression to Support Molecular Biology, Oncology, and Drug Discovery Research.

Zyme Communications
Healthcare and Life Science 18 Jun 2024

Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development

Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays

Zyme Communications
Healthcare and Life Science 17 Jun 2024

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

Brighton, UK: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, announces the appointment of Dr Renu Gupta as CMO (Chief Medical

Zyme Communications
Healthcare and Life Science 12 Jun 2024

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance Report in Journal of Cystic Fibrosis discloses best-in-class profile of ETD001 ETD001 scheduled to commence Phase 2 clinical study in p
Zyme Communications
Healthcare and Life Science 11 Jun 2024

Newcells Biotech strengthens executive and US team with key appointments

Dr Valeria Chichagova appointed as Director of Technology, Dr Colin Brown as Chief Scientific Officer, and Professor Lyle Armstrong as Scientific Advisor New US commercial appointments also announced to meet growing global demand for products and services
Zyme Communications
Healthcare and Life Science 06 Jun 2024

MediMab Biotherapeutics opens bespoke laboratory facilities, created by Kadans Science Partner, at Abingdon Science Park, UK

New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumours Kadans has also completed on Barton Hous
Zyme Communications
Healthcare and Life Science 05 Jun 2024

VALANX Biotech announces promising results in first in-vivo study of novel protein conjugate therapy

Study demonstrates pre-clinical efficacy of lead program VLX101 in treating autoimmune disease

Zyme Communications
Healthcare and Life Science 03 Jun 2024

DefiniGEN and Atelerix collaborate to ship in vitro cell models internationally without the need for freezing or cryopreservation

Cambridge and Newcastle UK: DefiniGEN Ltd., and Atelerix Ltd., announces they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US.

Zyme Communications
Healthcare and Life Science, Science and Engineering 30 May 2024

H.E.L Group extends sales and support with appointment of specialist distributors

Distributors will provide added application specific support for H.E.L’s biotechnology and chemical synthesis product portfolios in the USA, Spain and Portugal.

Zyme Communications
Healthcare and Life Science 29 May 2024

Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing

Partnership to develop and implement Cellular Origins’ robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult’s Stevenage Manufacturing Innovation Centre

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 12
  • Page 13
  • Current page 14
  • Page 15
  • Page 16
  • …
  • Next page ›
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS